← Leaderboards
Philip Louis Felgner
Gene Therapy Systems, Inc.
$23,823,979
Attributed
$23,823,979
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $34.9M · FY2005–24$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$56,940,046 · 17
By mechanism
U19$35,608,146 · 3
U01$12,425,192 · 3
R44$2,772,302 · 2
R01$2,100,911 · 1
R43$1,966,149 · 5
U54$1,072,316 · 2
Top collaborators
No co-investigators on record.
Most similar at Gene Therapy Systems, Inc.
Same institution · by research overlap
- David Allan Roth$2,358,200
Others in their field
Top investigators on “Antigens”
- Barton F Haynes · Duke University$488,918,563
- Lawrence Corey · Fred Hutchinson Cancer Center$325,880,100
- Dennis R. Burton · Scripps Research Institute$291,395,948
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$245,204,950
- Jeffrey P Krischer · University Of South Florida$208,289,343
- Dan H. Barouch · Fred Hutchinson Cancer Center$124,506,327
Research focus
AntigensProteinsSerumInfectionProtein MicrochipsBasePrintingResponseAntibodiesVaccinesSubunit VaccinesLaboratoriesProteomePlasmidsMonitorSamplingParasitesVaccine AntigenAnimalsMicroorganismCohortImmunityResearch PersonnelUniversities
Grant awards (48)
The UCI Vaccines for Pandemic Preparedness Center (VPPC)$33,116,067
U19 · FY2024 · AI · contact PI
Administrative Core$1,775,381
U19 · FY2024 · AI · contact PI
Predicting naturally acquired humoral immunity against malaria$372,904
R01 · FY2016 · AI · contact PI
Predicting naturally acquired humoral immunity against malaria$72,487
R01 · FY2016 · AI · contact PI
Predicting naturally acquired humoral immunity against malaria$393,380
R01 · FY2015 · AI · contact PI
Protective biomarkers for the development of vaccines against malaria$778,631
R44 · FY2014 · AI · contact PI
Predicting naturally acquired humoral immunity against malaria$459,962
R01 · FY2014 · AI · contact PI
CWRU procurement and administration for "Worldwide Population Serological Response$234,617
U19 · FY2014 · AI · contact PI
Protective biomarkers for the development of vaccines against malaria$780,873
R44 · FY2013 · AI · contact PI
Predicting naturally acquired humoral immunity against malaria$350,371
R01 · FY2013 · AI · contact PI
CWRU procurement and administration for "Worldwide Population Serological Respon$232,081
U19 · FY2013 · AI · contact PI
Protein Microarray$126,326
U54 · FY2013 · AI · contact PI
Predicting naturally acquired humoral immunity against malaria$68,530
R01 · FY2013 · AI · contact PI
Protective biomarkers for the development of vaccines against malaria$781,909
R44 · FY2012 · AI · contact PI
Multiplex Serodiagnostic Protein Microarray$699,474
U01 · FY2012 · AI · contact PI
Predicting naturally acquired humoral immunity against malaria$383,277
R01 · FY2012 · AI · contact PI
CWRU procurement and administration for "Worldwide Population Serological Respon$250,000
U19 · FY2012 · AI · contact PI
Protein Microarray$169,190
U54 · FY2012 · AI · contact PI
Multiplex Serodiagnostic Protein Microarray$740,101
U01 · FY2011 · AI · contact PI
Protein Microarray$146,741
U54 · FY2011 · AI · contact PI
Multiplex Serodiagnostic Protein Microarray$762,391
U01 · FY2010 · AI · contact PI
Protein Microarray$139,046
U54 · FY2010 · AI · contact PI
Multiplex Serodiagnostic Protein Microarray$747,612
U01 · FY2009 · AI · contact PI
Protein Microarray$142,208
U54 · FY2009 · AI · contact PI
Scanning B. pseudomallei proteome for vaccine antigens$1,023,198
U01 · FY2008 · AI · contact PI
Multiplex Serodiagnostic Protein Microarray$749,822
U01 · FY2008 · AI · contact PI
Protein Microarray and Expression Core$82,314
U54 · FY2008 · AI · contact PI
Scanning B. pseudomallei proteome for vaccine antigens$996,535
U01 · FY2007 · AI · contact PI
Protein Microarray and Expression Core$79,754
U54 · FY2007 · AI · contact PI
Scanning B. pseudomallei proteome for vaccine antigens$1,124,911
U01 · FY2006 · AI · contact PI
Scanning the F. tularensis Proteome for Vaccine Antigens$867,601
U01 · FY2006 · AI · contact PI
Adjuvants for Agile Vaccine Development$446,351
R43 · FY2006 · AI · contact PI
Scanning the P. falciparum proteome for vaccine antigens$300,389
R43 · FY2006 · AI · contact PI
Protein Microarray and Expression Core$103,356
U54 · FY2006 · AI · contact PI
Scanning B. pseudomallei proteome for vaccine antigens$1,007,395
U01 · FY2005 · AI
Scanning the F. tularensis Proteome for Vaccine Antigens$708,512
U01 · FY2005 · AI
Vaccinia Proteome Affinity Reagents From Phage Display$497,889
R41 · FY2005 · AI
Adjuvants for Agile Vaccine Development$440,494
R43 · FY2005 · AI
Scanning the P. falciparum proteome for vaccine antigens$298,279
R43 · FY2005 · AI
Protein Microarray and Expression Core$83,381
U54 · FY2005 · AI
Scanning B. pseudomallei proteome for vaccine antigens$1,566,070
U01 · FY2004 · AI
Scanning the F. tularensis Proteome for Vaccine Antigens$870,020
U01 · FY2004 · AI
Vaccinia Proteome Affinity Reagents From Phage Display$497,141
R41 · FY2004 · AI
Scanning the F. tularensis Proteome for Vaccine Antigens$561,550
U01 · FY2003 · AI
Intracellular Peptide Delivery Reagent$178,643
R43 · FY2002 · CA
PNA DEPENDENT GENE CHEMISTRY TO BOOST PLASMID EXPRESSION$430,889
R44 · FY2000 · CA
TRANSCRIPTIONALLY ACTIVE PCR FRAGMENTS$196,653
R43 · FY2000 · AI
SCREENING TRANSFECTION ENHANCERS$105,340
R43 · FY2000 · DK